arrow
Back
P

Peter Rossing

Steno Diabetes Center Copenhagen

120H-index
1.4KPaper Count
7.6WCitation Count
Published Papers 583
Publication Date
errShare
errSave
Prevalence, Incidence and Mortality of Chronic Kidney Disease in Type 1 and Type 2 Diabetes—A Nationwide Danish Register-Based Cohort Study
err2026-08-11
err0
PREAI
errChristina J.-Y. Lee; Thomas A. Gerds; Hjalte S. Mikkelsen; Pernille F. Rønn; Nicholas Carlson; Glenn M. Chertow; Dianna J. Magliano; Peter Rossing
errShare
errSave
Impact of Simultaneous Initiation of Finerenone and Empagliflozin on Albuminuria Irrespective of Baseline HbA1c Levels: A Participant-Level Exploratory Analysis of the Randomised CONFIDENCE Trial
err2026-08-05
err0
errOAAI
errJanet B. McGill; Jennifer B. Green; Hiddo J. L. Heerspink; Johannes F. E. Mann; Amy K. Mottl; Julio Rosenstock; Peter Rossing; Muthiah Vaduganathan; Masaomi Nangaku; Meike Brinker; Charlie Scott; Katja Rohwedder; Li Li; Na Li; Margarida Seco; Rajiv Agarwal
errShare
errSave
Impact of Albuminuria-Lowering Treatments on Cardiovascular Predictive Ceramides in Diabetes: Post Hoc Analysis of the ROTATE Trials
err2026-07-31
err0
errOAAI
errKristina Pigsborg; Simon Maria Kienle; Asger Wretlind; Viktor Rotbain Curovic; Martin Bæk Blond; Hiddo J. L. Heerspink; Tine Willum Hansen; Frederik Persson; Karolina Sulek; Cristina Legido-Quigley; Peter Rossing
errShare
errSave
A randomised clinical trial testing the safety of and metabolic responses to short-term duodenal infusion of recombinant RORDEP1 in healthy men
err2026-05-23
err0
errOAAI
errJoachim Gæde; Yong Fan; Liwei Lyu; Lærke Smidt Gasbjerg; Peter Rossing; Bolette Hartmann; Jens Juul Holst; Asger B. Lund; Filip K. Knop; Oluf Pedersen
errShare
errSave
Effects of Vicadrostat/Empagliflozin in People With Chronic Kidney Disease: Metabolic Subgroup Analyses
err2026-05-05
err0
errOAAI
errDavid Z. I. Cherney; Peter Rossing; Maria Eugenia Canziani; Maria Luiza Caramori; Ricardo Correa-Rotter; Lisa Cronin; Christian Hugo; Bo Ji; Juliane Meyerhoff; Masaomi Nangaku; Arnold Silva; Dorothea Urbach; Shimoli V. Shah; Dick de Zeeuw; Katherine R. Tuttle
errShare
errSave
Intra-Individual Variability of Urinary EGF and Clusterin, and Effect of Frozen Storage on Stability: Results from UVALID
err2026-04-27
err0
errOAAI
errErik Moedt; Rémon Vos; Wenjun Ju; Stephan J. L. Bakker; Marte O. Rygg; Peter Rossing; Michele Provenzano; Lilio Hu; Gaetano La Manna; Jose L. Gorriz; Francesc Moncho-Francés; Tobias B. Huber; Maja Lindenmeyer; Hiddo J. L. Heerspink; Elisabeth Meister
errShare
errSave
Outcomes With Finerenone by Baseline Treatment Goals in Type 2 Diabetes and Chronic Kidney Disease: A FIDELITY Analysis
err2026-04-24
err0
errOAAI
errJoão Sérgio Neves; Ana Rita Leite; Francisco Vasques-Nóvoa; Bertram Pitt; Gerasimos Filippatos; Luis M. Ruilope; Peter Rossing; Stefan D. Anker; Gianluigi Savarese; Charlie A. B. Scott; Andrea Lage; Meike D. Brinker; João Pedro Ferreira
errShare
errSave
Lifetime benefits of finerenone on cardiorenal morbidity and mortality in chronic kidney disease and type 2 diabetes: a pooled analysis of FIDELIO-DKD and FIGARO-DKD trials
err2026-04-07
err0
PREAI
errJohn W Ostrominski; Brendon L Neuen; Brian L Claggett; Rajiv Agarwal; Gerasimos Filippatos; Peter Rossing; Luis M Ruilope; Bertram Pitt; Meike Brinker; Andrea Lage; Patrick Schloemer; Katja Rohwedder; John J V McMurray; Scott D Solomon; Muthiah Vaduganathan; Stefan D Anker
errShare
errSave
Albuminuria and Carotid Atherosclerosis in Type 1 Diabetes Evaluated Using Three-Dimensional Vascular Ultrasound
err2026-03-30
err0
PREAI
errLuis F. Ferreira-Divino; Christina G. Poulsen; Viktor Rotbain Curovic; Lærke Urbak; Antoine Collet-Billon; Laurence Rouet; Marie Frimodt-Møller; Nikolaj Eldrup; Tine W. Hansen; Henrik Sillesen; Peter Rossing
errShare
errSave
Cumulative Effects of Vicadrostat and Empagliflozin on Albuminuria in CKD
err2026-02-10
err0
errOAAI
errPeter Rossing; Sibylle J. Hauske; Maria Eugenia Canziani; Maria Luiza Caramori; David Z.I. Cherney; Ricardo Correa-Rotter; Christian Hugo; Masaomi Nangaku; Arnold Silva; Dorothea Urbach; Dick de Zeeuw; Juliane Meyerhoff; Lisa Cronin; Zhichao Sun; Shimoli V. Shah; Katherine R. Tuttle
errShare
errSave
Once-weekly semaglutide versus placebo for the treatment of type 2 diabetes and chronic kidney disease in Denmark: A long-term cost-effectiveness analysis based on FLOW
err2025-12-20
err0
errOAAI
errPeter Rossing; Morten Lindhardt; Christian Klyver Tikkanen; Jyothi Menon; Juliette Cattin; Barnaby Hunt; Samuel J. P. Malkin; Barrie Chubb; Tina Damgaard; Rikke Borg
errShare
errSave
A FIDELITY Analysis on Finerenone With SGLT-2i and GLP-1RA in CKD
err2025-11-28
err0
errOAAI
errAjay K. Singh; Stefan D. Anker; Bertram Pitt; Peter Rossing; Luis M. Ruilope; Christiane Ahlers; Youssef M.K. Farag; Marc Lambelet; Meike D. Brinker; Katja Rohwedder; Gerasimos Filippatos
errShare
errSave
Timing of Cardiovascular and Kidney Benefits with Finerenone in Heart Failure and Chronic Kidney Disease with Type 2 Diabetes
errJACC
IF0
err2025-11-18
err0
errOAAI
errJohn W. Ostrominski; Brendon L. Neuen; Brian L. Claggett; Gerasimos Filippatos; Akshay S. Desai; Pardeep S. Jhund; Alasdair Henderson; Carolyn S.P. Lam; Michele Senni; Sanjiv J. Shah; Adriaan A. Voors; Faiez Zannad; Peter Rossing; Luis M. Ruilope; Stefan D. Anker; Bertram Pitt; Rajiv Agarwal; James Lay-Flurrie; Meike Brinker; Flaviana Amarante
errShare
errSave
Long-term risk of major adverse cardiovascular events in individuals with type 1 diabetes, albuminuria, and cardiac impairment
err2025-11-05
err0
PREAI
errE Frimodt-Moeller; H S Z Bahrami; A K Azar; T W Hansen; P Rossing; M T Jensen
errShare
errSave
Efficacy and safety of finerenone in Asian patients with type 2 diabetes and chronic kidney disease: A FIDELITY analysis by baseline kidney function
err2025-11-04
err0
PREAI
errShigehiro Katayama; Stefan D. Anker; Dalong Zhu; SungGyun Kim; Ming-Ju Wu; Daiji Kawanami; Peter Rossing; Luis Miguel Ruilope; Christiane Ahlers; Meike Brinker; Amaninder Mann; Yunjing Tian; Satoshi Yamashita; Bertram Pitt
errShare
errSave
Baseline Kidney Function, Albuminuria, and Urine Albumin-Creatinine Ratio Reduction with Finerenone, Empagliflozin, or Both Post Hoc Analyses of CONFIDENCE Trial
err2025-11-01
err0
PREAI
errMottl, Amy; Scott, Charlie; Green, Jennifer B.; Heerspink, Hiddo J. L.; Mann, Johannes F. E.; Mcgill, Janet B.; Nangaku, Masaomi; Rosenstock, Julio; Rossing, Peter; Li, Li; Li, Na; Vaduganathan, Muthiah; Agarwal, Rajiv
errShare
errSave
Protocol for the FibroCAN study: a randomised controlled trial of finerenone treatment for early-stage cardiovascular autonomic neuropathy in type 2 diabetes
err2025-10-22
err0
errOAAI
errBitsch Poulsen, Maria; Okdahl, Tina; Buciek, Jens Hove; Drewes, Asbjorn Mohr; Karlsson, Pall; Ahluwalia, Tarunveer Singh; Brock, Birgitte; Brock, Christina; Rossing, Peter; Hansen, Christian Stevns
errShare
errSave
Exome-wide analysis identifies a rare EXD3 missense variant associated with diabetic kidney disease
err2025-10-22
err0
errOAAI
errNiina Sandholm; Joanne B. Cole; Viji Nair; Eoin Brennan; Elena Giardini; Jani K. Haukka; Eunji Ha; Anna Syreeni; Emma H. Dahlström; Rany M. Salem; Damian Fermin; Josep Mercader; Laura Smyth; Claire Hill; Josyf Mychaleckyj; Stuart McGurnaghan; Rachel G. Miller; Tina Costacou; Barbara E.K. Klein; Janet Snell-Bergeon; Andrew D. Paterson; Rasa Verkauskiene; Jelizaveta Sokolovska; Nicolae Mircea Panduru; Gianpaolo Zerbini; Kerstin Brismar; Andrzej S. Krolewski; Valma Harjutsalo; Peter Rossing; Samy Hadjadj; Gareth McKay; Amy Jayne McKnight; Alexander P. Maxwell; Katalin Susztak; Catherine Godson; Matthias Kretzler; Joel N. Hirschhorn; Jose C. Florez; Per-Henrik Groop
errShare
errSave
Response to the letter to the editor entitled “Semaglutide and kidney function: direct kidney protection or an artifact?”
err2025-10-17
err0
PREAI
errVlado Perkovic; Katherine R. Tuttle; Peter Rossing; Johannes F.E. Mann; Thomas Idorn
errShare
errSave